Merit Medical’s Fred Lampropoulos Honored by Nasdaq
December 29, 2025
Nasdaq congratulated Fred Lampropoulos, founder and executive chairman of Merit Medical, on receiving the 2025 BioUtah Executive of the Year Award—a distinction reserved for executives whose vision and influence have not only propelled their organizations to sustained success but have also shaped the future of global healthcare.
Congratulations to Fred on receiving the well-deserved BioUtah award, as well as this recognition from Nasdaq!
Recent News
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
- Sera Prognostics Appoints Scott Gleason CFO
- Merit Medical Announces Global Operations Leadership Transition
- Utah Life Sciences Innovation Caucus Breakfast
- Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
